In contrast, in patients with benign breast tumors, the IL-6 level was not significantly correlated with the aforementioned indicators in routine blood tests but was positively correlated with cytokines IL-17, IFN-γ, and TNF-α. This evidence concerns the gene IL17A and breast benign neoplasm.